Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock.
Anne FreundSteffen DeschJanine PössDmitry S SulimovMarcus SandriNicolas MajunkeHolger ThielePublished in: Journal of clinical medicine (2022)
Mortality in infarct-related cardiogenic shock (CS) remains high, reaching 40-50%. In refractory CS, active mechanical circulatory support devices including veno-arterial extracorporeal membrane oxygenation (VA-ECMO) are rapidly evolving. However, supporting evidence of VA-ECMO therapy in infarct-related CS is low. The current review aims to give an overview on the basics of VA-ECMO therapy, current evidence, ongoing trials, patient selection and potential complications.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- acute myocardial infarction
- mechanical ventilation
- risk factors
- type diabetes
- cardiovascular disease
- intensive care unit
- acute coronary syndrome
- coronary artery disease
- mesenchymal stem cells
- left ventricular
- risk assessment
- atrial fibrillation
- bone marrow
- drug induced